FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2317078879> ?p ?o ?g. }

• W2317078879 endingPage "559" @default.
• W2317078879 startingPage "551" @default.
• W2317078879 abstract "Efficient and accurate adverse outcome pathway (AOP) based high-throughput screening (HTS) methods use a systems biology based approach to computationally model in vitro cellular and molecular data for rapid chemical prioritization; however, not all HTS assays are grounded by relevant in vivo exposure data. The challenge is to develop HTS assays with unambiguous quantitative links between in vitro responses and corresponding in vivo effects, which is complicated by metabolically insufficient systems, in vitro to in vivo extrapolation (IVIVE), cross-species comparisons, and other inherent issues correlating IVIVE findings. This article introduces the concept of ultrasensitive gas phase probe molecules (PrMs) to help bridge the current HTS assay IVIVE gap. The PrM concept assesses metabolic pathways that have already been well-defined from intact human or mammalian models. Specifically, the idea is to introduce a gas phase probe molecule into a system, observe normal steady state, add chemicals of interest, and quantitatively measure (from headspace gas) effects on PrM metabolism that can be directly linked back to a well-defined and corresponding in vivo effect. As an example, we developed the pharmacokinetic (PK) parameters and differential equations to estimate methyl tertiary butyl ether (MTBE) metabolism to tertiary butyl alcohol (TBA) via cytochrome (CYP) 2A6 in the liver from human empirical data. Because MTBE metabolic pathways are well characterized from in vivo data, we can use it as a PrM to explore direct and indirect chemical effects on CYP pathways. The PrM concept could be easily applied to in vitro and alternative models of disease and phenotype, and even test for volatile chemicals while avoiding liquid handling robotics. Furthermore, a PrM can be designed for any chemical with known empirical human exposure data and used to assess chemicals for which no information exists. Herein, we propose an elegant gas phase probe molecule-based approach to in vitro toxicity testing." @default.
• W2317078879 created "2016-06-24" @default.
• W2317078879 creator A5002145346 @default.
• W2317078879 creator A5068729346 @default.
• W2317078879 creator A5082190027 @default.
• W2317078879 date "2015-03-04" @default.
• W2317078879 modified "2023-09-23" @default.
• W2317078879 title "Probe Molecule (PrM) Approach in Adverse Outcome Pathway (AOP) Based High-Throughput Screening (HTS): <i>In Vivo</i> Discovery for Developing <i>in Vitro</i> Target Methods" @default.
• W2317078879 cites W1527821398 @default.
• W2317078879 cites W1579194856 @default.
• W2317078879 cites W1964514280 @default.
• W2317078879 cites W1967161228 @default.
• W2317078879 cites W1969727683 @default.
• W2317078879 cites W1970197319 @default.
• W2317078879 cites W1971154549 @default.
• W2317078879 cites W1975302305 @default.
• W2317078879 cites W1977015871 @default.
• W2317078879 cites W1979425216 @default.
• W2317078879 cites W1980223650 @default.
• W2317078879 cites W1980455299 @default.
• W2317078879 cites W1981827886 @default.
• W2317078879 cites W2000089305 @default.
• W2317078879 cites W2003336220 @default.
• W2317078879 cites W2004429971 @default.
• W2317078879 cites W2005205901 @default.
• W2317078879 cites W2007943064 @default.
• W2317078879 cites W2017890053 @default.
• W2317078879 cites W2021905427 @default.
• W2317078879 cites W2027254129 @default.
• W2317078879 cites W2030725327 @default.
• W2317078879 cites W2045113444 @default.
• W2317078879 cites W2047035495 @default.
• W2317078879 cites W2051175597 @default.
• W2317078879 cites W2054393093 @default.
• W2317078879 cites W2064576240 @default.
• W2317078879 cites W2075288278 @default.
• W2317078879 cites W2079710150 @default.
• W2317078879 cites W2092140452 @default.
• W2317078879 cites W2095853592 @default.
• W2317078879 cites W2104405356 @default.
• W2317078879 cites W2119619598 @default.
• W2317078879 cites W2122025333 @default.
• W2317078879 cites W2124046441 @default.
• W2317078879 cites W2131056563 @default.
• W2317078879 cites W2131674846 @default.
• W2317078879 cites W2135227744 @default.
• W2317078879 cites W2143909597 @default.
• W2317078879 cites W2147024107 @default.
• W2317078879 cites W2148699693 @default.
• W2317078879 cites W2150842632 @default.
• W2317078879 cites W2156816631 @default.
• W2317078879 cites W2156917500 @default.
• W2317078879 cites W2161364794 @default.
• W2317078879 cites W2162064655 @default.
• W2317078879 cites W2163286091 @default.
• W2317078879 cites W2163536623 @default.
• W2317078879 cites W2163879184 @default.
• W2317078879 cites W2164112244 @default.
• W2317078879 cites W2167631262 @default.
• W2317078879 cites W2168320789 @default.
• W2317078879 cites W2321944784 @default.
• W2317078879 cites W2334825103 @default.
• W2317078879 cites W2335463517 @default.
• W2317078879 cites W2742512161 @default.
• W2317078879 cites W4299822262 @default.
• W2317078879 cites W561642443 @default.
• W2317078879 cites W70559417 @default.
• W2317078879 doi "https://doi.org/10.1021/acs.chemrestox.5b00024" @default.
• W2317078879 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25692543" @default.
• W2317078879 hasPublicationYear "2015" @default.
• W2317078879 type Work @default.
• W2317078879 sameAs 2317078879 @default.
• W2317078879 citedByCount "16" @default.
• W2317078879 countsByYear W23170788792015 @default.
• W2317078879 countsByYear W23170788792016 @default.
• W2317078879 countsByYear W23170788792017 @default.
• W2317078879 countsByYear W23170788792018 @default.
• W2317078879 countsByYear W23170788792019 @default.
• W2317078879 countsByYear W23170788792020 @default.
• W2317078879 crossrefType "journal-article" @default.
• W2317078879 hasAuthorship W2317078879A5002145346 @default.
• W2317078879 hasAuthorship W2317078879A5068729346 @default.
• W2317078879 hasAuthorship W2317078879A5082190027 @default.
• W2317078879 hasConcept C112705442 @default.
• W2317078879 hasConcept C161624437 @default.
• W2317078879 hasConcept C185592680 @default.
• W2317078879 hasConcept C185867374 @default.
• W2317078879 hasConcept C207001950 @default.
• W2317078879 hasConcept C2910206359 @default.
• W2317078879 hasConcept C51323132 @default.
• W2317078879 hasConcept C54355233 @default.
• W2317078879 hasConcept C55493867 @default.
• W2317078879 hasConcept C60644358 @default.
• W2317078879 hasConcept C62231903 @default.
• W2317078879 hasConcept C70721500 @default.
• W2317078879 hasConcept C74187038 @default.
• W2317078879 hasConcept C86803240 @default.
• W2317078879 hasConcept C89311334 @default.

• next